Telisotuzumab vedotin
Catalog #: bp-50201
-
Overview
Telisotuzumab vedotin (Teliso-V, ABBV-399) is an antibody-drug conjugate (ADC) composed of the anti–c-Met humanized monoclonal antibody coupled to the cytotoxic monomethyl auristatin E (MMAE) through a mc-val-cit-PABC type linker. Telisotuzumab vedotin can be used for research on advanced solid tumours The DAR is n = ~3.71. This product is for research use only.Product Details Species Reactivity Human Type Antibody-drug conjugate ADC antibody Telisotuzumab (Anti-cMet) ADC cytotoxin (drug) MMAE Immunogen c-Met DAR (Drug to Antibody Ratio) ~3.71 Purity 99% Molecular Weight N/A Storage Condition Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. Storage Buffer 1x PBS -
Images
-
Datasheets and Documents